In case you missed it: April 25 to April 29
A look back at the week's news.
This week's top headlines:
FDA warn public of risks, false results with noninvasive prenatal screening tests
The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.
Coronavirus Omicron variant, vaccine, and case numbers in the United States: April 28, 2022
Omicron by the numbers.
Women’s health in review: April 2022
A look back at this month’s most popular stories, according to you.
Rotating shift work and onset of menopause
A Canadian study in Menopause suggests shift work may increase women's likelihood to experience delayed onset of menopause.
Prescription spending rose 12% in 2021
A report that tracks the use of medicines in the United States shows that spending on prescriptions rose 12% in 2021 primarily due to COVID-19 vaccines and therapies.
Reducing multifetal pregnancy through publicly funded IVF programs
April 26th 2024Learn how a mandatory elective single-embryo transfer policy in publicly funded in vitro fertilization programs significantly decreases multifetal pregnancy rates, offering insights into mitigating risks in assisted reproduction.
Read More
